Workshop D: Innovative MASH Treatment & Non-Invasive Fibrosis Testing: Advancing Multifunctional Drug Development & the Galactose Single Point Method
Time: 11:30 am
day: Clinical Track Workshop D
Details:
Delving into promising results for SNP-6 Series in treating MASH with multi-functional effects and a POC Quantitative Non-Invasive Test for MASH: Insights from animal and clinical trials. Showing clinically significant improvements in biomarkers of liver injury, inflammation, and fibrosis in a Phase 2 study in patients with MASH. Exploring a safe, simple, and highly sensitive quantitative liver function test. A potential new clinical management for subjects with NAFLD.
